image description

image description

For immediate release: September 2, 2025

Contact: [email protected] (mailto:[email protected])


** “AMERICA FIRST IN HEALTH RESEARCH”
------------------------------------------------------------

In latest Ripon Forum, Roy Blunt examines the importance of U.S. leadership in medical breakthroughs

Plus, Buddy Carter on the crisis facing the drug supply chain, Michael Baker on the positive impact of vaccines, and a profile of physician/lawmaker Greg Murphy
[link removed]
READ THE ISSUE ([link removed])

WASHINGTON, DC – At a time when spending in just about every area of the federal government is coming under intense scrutiny and review, the latest edition of The Ripon Forum examines the importance of investing in health research and why is it critical that the United States remain a global leader in that regard.

“There has been more change in healthcare and how we think about healthcare in the last 25 years than the collective healthcare advances of all time before that,” writes former Missouri Senator Roy Blunt ([link removed]) in the cover essay for this latest edition. “There are many reasons to believe that the next quarter century, and maybe even the next decade, will make the same kind of incredible progress.”

Blunt knows the issue better than most. Before his retirement from Congress in 2023, he served as Chairman of the Senate Appropriations subcommittee that funds the National Institutes of Health and other key federal healthcare agencies. In this position, he helped lead the effort to make sure America was a global leader in medical research. It is a priority, he said, that the federal government should renew its commitment to invest in today.

“The United States should commit itself to making the most of that next generation of healthcare and maintain our position as the world’s premier leader in medical breakthroughs,” Blunt writes. “When a country is first in health research, the people of that country benefit the most, but the economic opportunity of being first is also significant. Just a few of the areas that will rapidly develop include CRISPR technology, microbial medicine, the AI applications in healthcare research, and analyzing healthcare data.”

According to Georgia Congressman Buddy Carter ([link removed]) , lawmakers should also make it a priority to confront the crisis facing America’s pharmaceutical supply chain. “The United States should never be dependent on the Chinese Communist Party for antibiotics and essential medicines,” Carter writes in an essay. “But that’s exactly the dangerous position we are in today. In 2002, the United States manufactured 72 percent of the pharmaceuticals it consumed. By 2023, that number had dropped to just 37.5 percent. We didn’t just outsource manufacturing — we outsourced the sovereignty and safety of our health care system.”

In another essay, Michael Baker ([link removed]) of the American Action Forum examines the vital role that vaccines have played in American life over past six decades. “The creation, development, and deployment of vaccines – a U.S. federal priority since the 1960s – has been one of the greatest healthcare achievements in history,” Baker writes. “Routine childhood immunizations in the United States from 1994–2023 are estimated to have prevented around 508 million cases of illness, 32 million hospitalizations, and more than 1 million deaths.”

Also writing for this latest edition, Matthew E. Kahn ([link removed]) of the Hoover Institution examines the cost of chronic disease in America, while Dr. Vikas Saini ([link removed]) , the president of the Lown Institute, makes the case that America is overprescribed as a country and it is costing us billions of dollars each year. Lucy Orr-Ewing ([link removed]) of the Coalition for Health AI shares her thoughts on the future of artificial intelligence in health care, and, in our featured debate, Sally Pipes ([link removed]) , President & CEO of the Pacific Research Institute, squares off against USC's Paul Ginsburg & Steve Lieberman ([link removed]) of the Schaeffer Center in a discussion over drug prices and
whether the government should control them.

In the Forum's Politics & Perspective section, political observers Lee Drutman & Dustin Wahl ([link removed]) look at Nebraska Congressman Don Bacon’s decision to retire from Congress and whether there is room for his brand of centrist conservatism in American politics today. Alex Durante ([link removed]) of the Tax Foundation examines the hype and reality of today’s trade wars, and New Hampshire strategist Matthew Bartlett ([link removed]) assesses Governor Kelly Ayotte’s first six months in office.

In another essay, Forum editor Lou Zickar ([link removed]) examines author and attorney Philip K. Howard's latest book, Saving Can-Do, which follows up on the DOGE cuts taking place around Washington and asks a simple question — what comes next? And in the latest Ripon Profile, North Carolina Congressman Greg Murphy ([link removed]) discusses his career as a doctor and how that has shaped his service in the House.

The Ripon Forum is published six times a year by The Ripon Society, a public policy organization that was founded in 1962 and takes its name from the town where the Republican Party was born in1854 – Ripon, Wisconsin. One of the main goals of The Ripon Society is to promote the ideas and principles that have made America great and contributed to the GOP’s success. These ideas include keeping our nation secure, keeping taxes low and having a federal government that is smaller, smarter and more accountable to the people.

For more information on The Ripon Society, please visit www.riponsociety.org ([link removed]) .

–###–
[link removed]
[link removed]
[link removed]
[link removed]
[link removed]
[link removed]

The Ripon Society is a non-profit corporation organized under the laws of the District of Columbia. It is exempt from federal income taxation pursuant to section 501 (c) (4) of the Internal Revenue Code. The Ripon Society does not make contributions or expenditures to influence elections. In addition, The Ripon Society does not engage in other election activities, including voter registration, voter identification, get-out-the-vote activity, or generic campaign activity, collectively referred to as "federal election activity" in the Bipartisan Campaign Reform Act of 2002. Donations from corporations, organizations or individuals are accepted.

View email in browser ([link removed])
The Ripon Society . 1155 15th St NW Ste 550 . Washington, DC xxxxxx-2713 . USA
update your preferences ([link removed]) or unsubscribe ([link removed])